Research Article: Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma
Abstract:
Introduction: Infections are a leading cause of morbidity and mortality in patients with multiple myeloma (MM).
No summary available.